[go: up one dir, main page]

DE69230105D1 - Differentielle bindungsaffinitäten und darauf beruhende dissoziationstestverfahren - Google Patents

Differentielle bindungsaffinitäten und darauf beruhende dissoziationstestverfahren

Info

Publication number
DE69230105D1
DE69230105D1 DE69230105T DE69230105T DE69230105D1 DE 69230105 D1 DE69230105 D1 DE 69230105D1 DE 69230105 T DE69230105 T DE 69230105T DE 69230105 T DE69230105 T DE 69230105T DE 69230105 D1 DE69230105 D1 DE 69230105D1
Authority
DE
Germany
Prior art keywords
receptor
analyte
pct
ligand
differential binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69230105T
Other languages
English (en)
Other versions
DE69230105T2 (de
Inventor
Judith Fitzpatrick
Regina Lenda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Serex Inc
Original Assignee
Serex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serex Inc filed Critical Serex Inc
Application granted granted Critical
Publication of DE69230105D1 publication Critical patent/DE69230105D1/de
Publication of DE69230105T2 publication Critical patent/DE69230105T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Treating Waste Gases (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Peptides Or Proteins (AREA)
  • Paper (AREA)
  • Amplifiers (AREA)
DE69230105T 1991-07-29 1992-07-29 Differentielle bindungsaffinitäten und darauf beruhende dissoziationstestverfahren Expired - Fee Related DE69230105T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73752691A 1991-07-29 1991-07-29
PCT/US1992/006249 WO1993003367A1 (en) 1991-07-29 1992-07-29 Differential binding affinities and dissociation assays based thereon

Publications (2)

Publication Number Publication Date
DE69230105D1 true DE69230105D1 (de) 1999-11-11
DE69230105T2 DE69230105T2 (de) 2000-01-20

Family

ID=24964268

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69230105T Expired - Fee Related DE69230105T2 (de) 1991-07-29 1992-07-29 Differentielle bindungsaffinitäten und darauf beruhende dissoziationstestverfahren

Country Status (6)

Country Link
US (1) US5527686A (de)
EP (1) EP0600936B1 (de)
AT (1) ATE185424T1 (de)
AU (1) AU2402292A (de)
DE (1) DE69230105T2 (de)
WO (1) WO1993003367A1 (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356784A (en) * 1993-03-30 1994-10-18 Terrapin Technologies, Inc. Determination of concentration by affinity titration
CA2157929A1 (en) * 1993-03-30 1994-10-13 Lawrence M. Kauvar Determination of concentration by affinity titration and competitive displacement in drug delivery
US5500375A (en) 1993-04-13 1996-03-19 Serex, Inc. Integrated packaging-holder device for immunochromatographic assays in flow-through or dipstick formats
GB9313163D0 (en) * 1993-06-25 1993-08-11 Health Lab Service Board Storage of antibodies
US5710009A (en) * 1994-02-17 1998-01-20 Serex, Inc. Receptor:release ligand (reland) complexes and release assays using said reland and methods and kits based thereon
WO1996016332A1 (en) * 1994-11-24 1996-05-30 Unipath Limited Recovery of and uses of specific binding agents
DE19504198A1 (de) * 1995-02-09 1996-08-14 Behringwerke Ag Kompetitiver Immuntest unter Verwendung komplexierter Analytderivate
AU739280B2 (en) * 1995-06-22 2001-10-11 Serex, Inc. Receptor: release ligand (reland) complexes and assays and kits based thereon
US5935790A (en) * 1996-08-06 1999-08-10 Rutgers, The State University Of New Jersey Method for detecting a predisposition to susceptibility to toxic effects of drugs and poisons
US5710005A (en) * 1996-10-29 1998-01-20 Biocode, Inc. Analyte detection with a gradient lateral flow device
US6710036B2 (en) 1997-07-25 2004-03-23 Avigen, Inc. Induction of immune response to antigens expressed by recombinant adeno-associated virus
US6238905B1 (en) 1997-09-12 2001-05-29 University Technology Corporation Thermophilic polymerase III holoenzyme
US6875606B1 (en) 1997-10-23 2005-04-05 The United States Of America As Represented By The Department Of Veterans Affairs Human α-7 nicotinic receptor promoter
US6225456B1 (en) 1998-05-07 2001-05-01 University Technololy Corporation Ras suppressor SUR-5
US6506889B1 (en) 1998-05-19 2003-01-14 University Technology Corporation Ras suppressor SUR-8 and related compositions and methods
US20020131972A1 (en) * 1998-05-21 2002-09-19 Daniel Sem Multi-partite ligands and methods of identifying and using same
US6221349B1 (en) 1998-10-20 2001-04-24 Avigen, Inc. Adeno-associated vectors for expression of factor VIII by target cells
US6200560B1 (en) 1998-10-20 2001-03-13 Avigen, Inc. Adeno-associated virus vectors for expression of factor VIII by target cells
US6472222B2 (en) 1999-02-16 2002-10-29 Via Christi Research, Inc. Method of estimating rate of nicotine metabolism in individuals
US6558911B1 (en) 1999-12-10 2003-05-06 Oregon Health Sciences University Sperm quality assay
US6677146B1 (en) 2000-03-28 2004-01-13 Replidyne, Inc. Thermophilic polymerase III holoenzyme
US6699722B2 (en) 2000-04-14 2004-03-02 A-Fem Medical Corporation Positive detection lateral-flow apparatus and method for small and large analytes
US6573370B1 (en) 2000-05-19 2003-06-03 Regents Of The University Of Michigan PON3 and uses thereof
US7060442B2 (en) 2000-10-30 2006-06-13 Regents Of The University Of Michigan Modulators on Nod2 signaling
US6849449B2 (en) 2001-03-01 2005-02-01 Regents Of The University Of Michigan Orphanin FQ receptor nucleic acids
US7653490B2 (en) * 2001-09-10 2010-01-26 Triad Liquidating Company LLC Nuclear magnetic resonance assembly of chemical entities
US20030059850A1 (en) * 2001-09-26 2003-03-27 Psychiatric Genomics, Inc. Fluorescence proximity assay
US7255986B2 (en) 2002-01-31 2007-08-14 The Board Of Trustees Operating Michigan State University Compositions for the diagnosis and treatment of epizootic catarrhal enteritis in ferrets
US20030180797A1 (en) * 2002-03-20 2003-09-25 Lin Yu Identification of ligands for a receptor family and related methods
US20040203079A1 (en) 2003-04-09 2004-10-14 Research Foundation Of The State University Of New York Methods and kits for detecting cerebrospinal fluid in a sample
US20070003992A1 (en) * 2003-04-09 2007-01-04 Pentyala Srinivas N Methods and kits for detecting cerebrospinal fluid in a sample
US8003765B2 (en) 2003-04-09 2011-08-23 Stony Brook Anaesthesiology, University Faculty Practice Corporation Methods, antibodies and kits for detecting cerebrospinal fluid in a sample
US7173010B2 (en) 2003-05-19 2007-02-06 Regents Of The University Of Michigan Orphanin FQ receptor
US7655833B2 (en) 2003-05-29 2010-02-02 Brookhaven Science Associates, Llc ADS genes for reducing saturated fatty acid levels in seed oils
US8007725B2 (en) 2003-11-07 2011-08-30 Princeton Biochemicals, Inc. Electrophoresis apparatus having valve system
US7432057B2 (en) 2004-01-30 2008-10-07 Michigan State University Genetic test for PSE-susceptible turkeys
US7858323B2 (en) 2004-06-09 2010-12-28 The Regents Of The University Of Michigan Phage microarray profiling of the humoral response to disease
US8563328B2 (en) * 2004-07-26 2013-10-22 University Of Louisville Research Foundation, Inc. Fiber-optic biosensor and biosensing methods
US7229782B1 (en) 2004-08-03 2007-06-12 Labone, Inc. Antibodies specific to multiple beta blockers and methods for their use
US20100256062A1 (en) 2004-12-06 2010-10-07 Howard Tommy E Allelic Variants of Human Factor VIII
WO2006088976A2 (en) * 2005-02-16 2006-08-24 University Of Louisville Research Foundation, Inc. Fiber-optic biosensor and biosensing methods
WO2007057428A1 (en) * 2005-11-17 2007-05-24 Epfl - Ecole Polytechnique Federale De Lausanne Chromophore containing ligands for characterisation of receptors for binding and activation
US20120149884A1 (en) * 2006-11-22 2012-06-14 3M Innovative Properties Company Specific antibody selection by selective elution conditions
CA2705486C (en) 2007-11-19 2019-04-02 Celera Corporation Lung cancer markers and uses thereof
CA2807645C (en) 2009-08-07 2021-09-07 Affinimark Technologies, Inc. Device and methods for the immunological identification of cerebrospinal fluid
US20110177107A1 (en) 2010-01-14 2011-07-21 Haplomics, Inc. Predicting and reducing alloimmunogenicity of protein therapeutics
EP3450979A3 (de) 2010-03-17 2019-04-24 The Regents of The University of Michigan Verwendung von phagenepitopen zur profilierung einer immunreaktion
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
WO2012129128A1 (en) * 2011-03-18 2012-09-27 Biotium, Inc. Fluorescent dyes, fluorescent dye kits, and methods of preparing labeled molecules
CN102809650B (zh) * 2012-08-29 2015-02-11 沃克(天津)生物科技有限公司 生物素化牛丙种球蛋白-链霉亲和素酶标板及其制备方法
US10272163B2 (en) 2012-12-07 2019-04-30 The Regents Of The University Of California Factor VIII mutation repair and tolerance induction
CN104034893B (zh) * 2013-03-08 2016-04-20 北京普析通用仪器有限责任公司 一种基于胶乳的三聚氰胺快速检测方法及试剂盒
JP2017521654A (ja) 2014-06-27 2017-08-03 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ ヒトペギウイルス２（ＨＰｇＶ−２）を検出するための組成物および方法
WO2017142956A1 (en) * 2016-02-16 2017-08-24 Walkill Concepts, Inc. Methods, compositions and devices for improving the sensitivity of assays
CN106053788A (zh) * 2016-07-21 2016-10-26 苏州博源医疗科技有限公司 一种可替宁均相酶免疫检测试剂及其制备和检测方法
WO2020078999A1 (en) 2018-10-15 2020-04-23 F. Hoffmann-La Roche Ag Immunoassay for measuring c-peptide

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817837A (en) * 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3875011A (en) * 1972-11-06 1975-04-01 Syva Co Enzyme immunoassays with glucose-6-phosphate dehydrogenase
US3917582A (en) * 1973-06-13 1975-11-04 Syva Corp Isothiocyanate and thiourea derivatives of benzoyl ecgonine conjugated to polypeptides
US4383031A (en) * 1975-04-28 1983-05-10 Miles Laboratories, Inc. Homogeneous chemiluminescent specific binding assay
US4069105A (en) * 1977-03-03 1978-01-17 Syva Company Lidocaine antigens and antibodies
US4115535A (en) * 1977-06-22 1978-09-19 General Electric Company Diagnostic method employing a mixture of normally separable protein-coated particles
US4318707A (en) * 1978-11-24 1982-03-09 Syva Company Macromolecular fluorescent quencher particle in specific receptor assays
US4323507A (en) * 1979-02-12 1982-04-06 Syva Company Valproate conjugation using dicarbonyls
US4341866A (en) * 1980-06-02 1982-07-27 Syva Company Antienzyme termination in enzyme immunoassays
US4590278A (en) * 1981-01-29 1986-05-20 Philip Morris Incorporated Nicotine analogs
US4480042A (en) * 1981-10-28 1984-10-30 E. I. Du Pont De Nemours And Company Covalently bonded high refractive index particle reagents and their use in light scattering immunoassays
US4504413A (en) * 1982-04-02 1985-03-12 Syva Company Acetaminophen analogs, antigens, and antibodies
US4434236A (en) * 1982-10-20 1984-02-28 E. I. Du Pont De Nemours & Co. Immunoassay wherein labeled antibody is displaced from immobilized analyte-analogue
US4551426A (en) * 1983-10-03 1985-11-05 E. I. Du Pont De Nemours And Company Heterogeneous immunoassay for digoxin using ouabain as a separation means
US4766064A (en) * 1984-05-07 1988-08-23 Allied Corporation Displacement polynucleotide assay employing polyether and diagnostic kit
US4977077A (en) * 1984-10-24 1990-12-11 Bioprobe International Integrated solid-phase immunoassay
JPH0750114B2 (ja) * 1986-03-17 1995-05-31 富士写真フイルム株式会社 免疫分析器具を用いる分析方法
US5137808A (en) * 1987-04-07 1992-08-11 Syntex (U.S.A.) Inc. Immunoassay device
US5009998A (en) * 1987-06-26 1991-04-23 E. I. Du Pont De Nemours And Company Method for performing heterogeneous immunoassay
US5028535A (en) * 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
JPH02213766A (ja) * 1989-02-15 1990-08-24 Mochida Pharmaceut Co Ltd 免疫測定用試薬および免疫測定器具
DE3922960A1 (de) * 1989-07-12 1991-01-17 Boehringer Mannheim Gmbh Verfahren zur bestimmung eines analyten
US5183740A (en) * 1990-02-23 1993-02-02 The United States Of America As Represented By The Secretary Of The Navy Flow immunosensor method and apparatus
US5164504A (en) * 1991-01-16 1992-11-17 Abbott Laboratories Haptens, tracers, immunogens and antibodies for immunoassays for cotinine derivatives

Also Published As

Publication number Publication date
ATE185424T1 (de) 1999-10-15
US5527686A (en) 1996-06-18
WO1993003367A1 (en) 1993-02-18
DE69230105T2 (de) 2000-01-20
EP0600936A4 (en) 1996-08-28
EP0600936B1 (de) 1999-10-06
EP0600936A1 (de) 1994-06-15
AU2402292A (en) 1993-03-02

Similar Documents

Publication Publication Date Title
DE69230105D1 (de) Differentielle bindungsaffinitäten und darauf beruhende dissoziationstestverfahren
DK0692097T3 (da) Anordning til chromatografisk bestemmelse, der indeholder modsatstillede dele
TW356519B (en) A device for highest sensitivity magnetic detection of analytes
CA2103052A1 (en) Assay device
EP0399184A3 (de) Reagenzien, Verfahren und Testsätze zum Nachweis von Amphetaminen durch einen Fluoreszenz-Polarisations-Immunoassay
PL309211A1 (en) Heterogenous specific bond test used for detection or content determination of a given substance in a sample analysed, method of reducing non-specific bonding in pseudohomogenous tests and testing set for performing immunological test and those employing genetic probe
EP0797777A4 (de) Vorrichtung zur durchführung eines oder mehrerer kompetitiver ummunoassays
NO903124D0 (no) Testmetode og reagenssett for denne.
IL101233A (en) Receptor-based screening and identifying methods for amylin agonists and antagonists
ATE169117T1 (de) Sensoreinrichtung zum sandwichtest
DE69714584D1 (de) Immunoassays zum nachweis von antiphospholipid-antikörpern
CA2471462A1 (en) Internal calibration system for flow-through assays
PT97839A (pt) Processo para a deteccao e/ou doseamento de hormonas e anticorpos utilizaveis no referido processo de deteccao
DK0728309T3 (da) Analyseindretninger og fremstilling heraf
DE69604920D1 (de) Verwendung einer phycobiliprotein-peptidkomplexverbindung als fluoreszenzlabel
CA2225210A1 (en) Receptor:release ligand (reland) complexes and assays and kits based thereon
ATE320604T1 (de) Homogene nachweisverfahren zur bestimmung von subpopulationen eines analyten
ATE354800T1 (de) Verfahren zum nachweiss von antikörpern in einer probe
EP0672062A4 (de) Eine petroleum immuntestmethode, ihre komponenten und kit für deren anwendung.
CA2021658A1 (en) Multiplex immunoassay system
DE69725118D1 (en) Reagentien für tests für mycophenolsäure
CA2114440A1 (en) Differential binding affinities and dissociation assays based thereon
DK1200826T3 (da) Immunoassay og testanordning med integreret reference
TW246718B (en) Immunoassay for detecting HCV IgM antibody
ES2004066A6 (es) Metodo para analisis cualitativo y-o cuantitativo de antigenos,anticuerpos yno microorganismos u otras celulas y su correspondiente equipo

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: VONNEMANN, KLOIBER & KOLLEGEN, 80796 MUENCHEN

8339 Ceased/non-payment of the annual fee